Anna Baranova

Anna Baranova

Auto-generated profile, based on publicly available information

Anna Baranova

Kharkiv National Medical University of the Ministry of Health of Ukraine, Kharkiv, Ukraine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Journal of Medicine and Life
Verified
Journal Article
Open access
ABAnna Baranova
Anna Baranova
MKMykola Krasnoselskyi
Mykola Krasnoselskyi
VSVolodymyr Starikov
Volodymyr Starikov
SKSergii Kartashov
Sergii Kartashov
IZIgor Zhulkevych
Igor Zhulkevych
YVYurii Vinnyk
Yurii Vinnyk
Breast cancer is the most common cancer in women and the most common cause of death in working-age women. According to the results of immunohistochemical studies, 10–20% of cases revealed a triple-negative type of breast cancer. This subtype is characterized by significant proliferative activity and growth rate, aggressive clinical course, and early metastasis. This leads to a suspicious prognosis and, accordingly, encourages an increase of surgical treatment radicalism and aggressive systemic treatment. This review briefly analyzes existing treatment strategies for triple-negative breast cancer with a focus on surgical treatment. Surgical treatment is an integral part of complex therapy. Currently, the attention of researchers is focused not only on the radicalism of the operation, ensuring long-term survival, but also on achieving a good cosmetic result that determines the quality of life of patients. In this aspect, organ-preserving and prosthetic methods of operations are promising, the feasibility and effectiveness of which are being discussed. The relevance of choosing the optimal method of operation is evidenced by the lack of generally accepted approaches based on informative markers for the prognosis of the course of the disease. Therefore, the choice of the optimal method of surgical treatment taking into account the individual characteristics of the patient and the tumor, indications for chemotherapy, and radiation therapy remains an unresolved issue and requires further research.

30 January 2020 in ScienceRise: Medical Science
Verified
Journal Article
Open access
PDF file
YVYuriy Vinnyk
Yuriy Vinnyk
VVVadim Vlasenko
Vadim Vlasenko
ABAnna Baranova
Anna Baranova
Постмастектомічний синдром (ПМЕС) вважається одним з найбільш частих ускладнень після радикальних операцій у хворих на рак молочної залози (РМЗ). Мета дослідження – визначення факторів ризику та розробка заходів профілактики ПМЕС після радикальних операцій у хворих на РМЗ. Матеріали і методи. Проаналізовано безпосередні результати хірургічного лікування 147 жінок з РМЗ, що перенесли радикальну операцію: частоту післяопераційного набряку та ПМЕС залежно від вихідних клініко-патологічних показники та особливостей лікування з використанням методів описової статистики, критерію χ2 та кореляційного аналізу. Результати. ПМЕС протягом періоду спостереження діагностовано у 17 (11,6 %) пацієнток, у тому числі: І ст. – у 7 (4,8 %); ІІ ст. – у 9 (6,1 %) та ІІІ ст. в одному випадку (0,7 %). У більшості випадків його розвиток асоціювався з післяопераційним набряком, що виявлявся у ранньому післяопераційному періоді (в 15 (88 %). Встановлено залежність частоти розвитку ПМЕС від ІМТ та віку хворих з тенденцією до її збільшення при застосуванні ад’ювантної променевої терапії та зменшення при первинній пластики молочної залози. Застосування комплексу профілактичних заходів призвело до зменшення частоти ПМЕС (з 17 % до 2 %). Висновки. У хворих на РМЗ частим ускладненням радикальних операцій є післяопераційний набряк верхньої кінцівки та/або ПМЕС, ризик яких збільшується зі зростанням віку та ІМТ, а також при застосування ад’ювантної променевої терапії. Застосування комплексу профілактичних заходів сприяє достовірному зменшенню частоти цих ускладнень

31 January 2020 in EUREKA: Health Sciences
Verified
Journal Article
Open access
PDF file
YVYuri Vinnyk
Yuri Vinnyk
VVVadym Vlasenko
Vadym Vlasenko
ABAnna Baranova
Anna Baranova
Breast cancer is one of the most common malignancies in women. In many cases, a major component of complex treatment for breast cancer is surgery - radical mastectomy or radical breast resection. The aim of the work – to investigate the frequency and structure of complications after radical surgery with dissection of axillary lymph nodes in breast cancer patients. Material and methods. The baseline and surgical results of 147 women with breast cancer who underwent radical mastectomy or radical breast resection with lymph node dissection were analysed. Results. Complications in the early period after surgery for breast cancer were found in 76 (51.7 %), including postoperative extremity edema in 60 (40.8 %); lymphorrhea – in 37 (25.2 %), seroma – in 33 (22.4 %); wound infection in 18 (12.2 %), necrosis of the wound edges – in 15 (10.2 %) patients. Correlation of postoperative edema with almost all other complications was found, lymphorrhea and seroma were most associated with swelling and with each other; necrosis of edges with postoperative edema. Wound infection was significantly associated with lymphorrhea. Patients' age, stage of disease, and immunohistochemical type of tumour did not affect the development of complications. With increasing BMI, the incidence of complications increased significantly (χ2=9.530; p=0.009). The tendency to decrease the frequency of complications during reconstructive surgery was revealed (42.6 % versus 58.1 %, p=0.064), and adjuvant radiotherapy, on the contrary, contributed to the increase of complications (57.8 % versus 43.8 %, p=0.090). Conclusion. Radical operations with lymph node dissection in patients with breast cancer are characterized by a high frequency of early postoperative complications, mainly associated with disorders of lymphatic outflow, which indicates the need for a set of measures of preoperative preparation, improvement of surgical technique.

20 December 2019 in Klinicheskaia khirurgiia
Verified
Journal Article
Open access
PDF file
YVYu. O. Vinnyk
Yu. O. Vinnyk
VVV. G. Vlasenko
V. G. Vlasenko
ABA. V. Baranova
A. V. Baranova
Objective. Elaboration of prophylactic measures for complications after radical operations in patients, suffering mammary gland cancer, and estimation of its efficacy. Materials and methods. Immediate results of surgical treatment were analyzed in 147 patients, suffering mammary gland cancer, and distributed, depending on perioperative treatment methods, into: the1st (comparison group) - 92 women-patients, to whom a standard treatment was applied, the second one (main group) - 55 women-patients, in whom complex of prophylactic measures was applied, including organizational, as well as compressive and medicinal therapy. Results. Application of complex of prophylactic measures was accompanied by reduction of the development rate of postoperative oedema from 50% (comparison group) to 25% (p=0.003), the seroma’s formation - from 29 to 11% (p=0.010), development and severity of postmastectomy syndrome, lymphorrhea - from 29 to 18% (p=0,131) and the wounds complications - from 25 to 7.3% (p=0.007). Conclusion. After radical operations with the lymph node dissection in patients, suffering mammary gland cancer, the early morbidity rate is rather high, and mainly connected with lymphovenous drainage outflow. The complex of measures, aiming at minimization of the patients’ stationary stay, early extraction of draining tubes, early activation of the patients, the improved compressive and medicinal therapy permits to reduce the rate and severity of morbidity and to accelerate the patients’ recovery and reconvalescence.

3 December 2024 in Український радіологічний та онкологічний журнал
Verified
Journal Article
Open access
PDF file
OMO.V. Muzhychuk
O.V. Muzhychuk
VSV.I. Starikov
V.I. Starikov
VLV.M. Lykhman
V.M. Lykhman
ISI.A. Sennikov
I.A. Sennikov
DYD.V. Yevtushenko
D.V. Yevtushenko
АГА.ю. Гаврілов
А.ю. Гаврілов
Background. Multiple molecular alterations are observed in breast cancer. Among the functions attributed to lncRNA-BORG are various carcinogenic processes that function during the formation chemoresistant and recurrence of primary tumors. In this study, we aimed to identify lncRNA BORG expression signature, that can predict breast cancer patient recurrence-free survival. Purpose – evaluate long non-coding RNA expression as diagnostic marker for disease prognosis and prediction of treatment effect. Materials and Methods. A total of 40 advanced resistant breast cancer patients were divided into two groups: 1) Basal and Luminal B HER-2 positive (n = 20); 2) Luminal A (n = 20), were obtained with overall survival compared with relapse-free status patients. The bioinformatics prediction is confirmed by polymerase chain reaction (PCR). To investigate the prognostic accuracy of multi-lncRNA BORG-based classifier, time-dependent receiver operating characteristic analysis was performed using the ‘survival ROC’ R package. Relapse-free survival was analyzed based on Kaplan–Meier method, and the log-rank test was performed to assess the statistical significance of the differences. Results. High lncRNA BORG protein expression was shown to have the highest correlation with positive hormone status (OR = 2.79; 95% confidence interval (95% CI), 1.27 – 4.20). Furthermore, HER2 overexpression (OR = 1.65; 95% CI, 1.26 – 2.13) was linked to important hormone status. Patients with HER2 positive/lncRNA BORG present high expression had a fourfold increased risk of relevant hormone status compared to patients with HER2 negative/lncRNA BORG show low expression, and an estimated 16.4% cumulative risk of recurrence developing relevant at two years. We discovered a predictive function for lncRNA BORG for identification, which has the potential to enhance clinical care of women with Advanced Breast Cancer (ABC). High HER2-positive/lncRNA BORG expression was linked to ER-negative disease recurrences. Our findings highlight the necessity of assessing protein expression of HER2 and lncRNA BORG to evaluate the probability of disease recurrence in ABC patients following diagnosis and therapy. Patients with low lncRNA BORG expression had a recurrence risk that is equivalent to the general population. Conclusions. We discovered a predictive function for lncRNA BORG for identification, which has the potential to enhance clinical care of women with ABC. Women with HER2-positive/lncRNA BORG high expression lesions had a fourfold greater frequency of subsequent hormone status than women with HER2-negative/ lncRNA BORG low expression lesions. High HER2-positive/lncRNA BORG expression was linked to ER-negative disease chemoresistance and recurrence. Our findings highlight the necessity of assessing protein expression of HER2 and lncRNA BORG to evaluate the probability of disease recurrence in ABC patients following diagnosis and therapy. Patients with low lncRNA BORG expression had chemoresistance and a high recurrence risk that is equivalent to the general population.